This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: renin angiotensin system

October 2020 Br J Cardiol 2020;27:109–11 doi:10.5837/bjc.2020.031

Neprilysin inhibitors and angiotensin(1–7) in COVID-19

Nathalie Esser, Sakeneh Zraika

Abstract

The issue regarding use of RAS blockers in the context of COVID-19 has previously been reviewed.1,2 Most recently, emerging data suggest no harm is associated with use of ACE inhibitors or ARBs in COVID-19.3,4 In this perspective, we discuss a related aspect that was first raised by Acanfora and colleagues,5 namely, the potential benefit of neprilysin inhibitors and their role in modulating levels of RAS components. Similar to the situation for ACE inhibitors and ARBs, it seems there are mixed opinions on the utility of neprilysin inhibitors in COVID-19. In a recent review, it was postulated that increasing neprilysin activity might mitigate

| Full text

May 2006 Br J Cardiol 2006;13:174-6

The American Society of Hypertension 21st Annual Scientific Meeting

Martin Godfrey

Abstract

No content available

| Full text

July 2004 Br J Cardiol 2004;11:287-90

Diurnal rhythms, the renin-angiotensin system and antihypertensive therapy

Michael Schachter

Abstract

No content available

| Full text

March 2004 Br J Cardiol 2004;11:123-27

Inhibition of the renin-angiotensin system in diabetic patients – beyond HOPE

Anthony H Barnett

Abstract

No content available

| Full text

October 2002 Br J Cardiol 2002;9:533-7

Aldosterone antagonism: new ideas, new drugs

Mike Schachter

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now